We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$135B
AUM Growth
+$4.04B
Cap. Flow
-$3.98B
Cap. Flow %
-2.96%
Top 10 Hldgs %
18.27%
Holding
2,869
New
86
Increased
1,174
Reduced
804
Closed
106

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$155M
2
WFC icon
Wells Fargo
WFC
+$134M
3
BIIB icon
Biogen
BIIB
+$121M
4
BABA icon
Alibaba
BABA
+$108M
5
DAL icon
Delta Air Lines
DAL
+$107M

Sector Composition

Rank Sector Weight
1 Technology 18.93%
2 Financials 14.16%
3 Healthcare 13.87%
4 Consumer Discretionary 11.78%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWS icon
2451
iShares Russell Mid-Cap Value ETF
IWS
$16B
$161K ﹤0.01%
1,785
-26
-1% -$2.35K
AKBA icon
2452
Akebia Therapeutics
AKBA
$251M
$157K ﹤0.01%
17,800
HEDJ icon
2453
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
$156K ﹤0.01%
4,926
-198
-4% -$6.35K
LKSD
2454
DELISTED
LSC Communications, Inc.
LKSD
$155K ﹤0.01%
13,972
BLCM
2455
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$153K ﹤0.01%
2,490
BNS icon
2456
Scotiabank
BNS
$108B
$152K ﹤0.01%
2,547
-4,357,529
-100% -$255M
ESND
2457
DELISTED
Essendant Inc.
ESND
$151K ﹤0.01%
11,799
RMTI icon
2458
Rockwell Medical
RMTI
$28.3M
$149K ﹤0.01%
320
HEFA icon
2459
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.69B
$148K ﹤0.01%
4,931
+366
+8% +$10.8K
ELGX
2460
DELISTED
Endologix Inc
ELGX
$142K ﹤0.01%
7,450
GSAT icon
2461
Globalstar
GSAT
$10.7B
$138K ﹤0.01%
18,085
UCFC
2462
DELISTED
United Community Financial Corp
UCFC
$137K ﹤0.01%
14,200
SGYP
2463
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$137K ﹤0.01%
80,394
VONG icon
2464
Vanguard Russell 1000 Growth ETF
VONG
$44.9B
$135K ﹤0.01%
3,376
-432
-11% -$16.8K
HSBC icon
2465
HSBC
HSBC
$355B
$134K ﹤0.01%
3,206
-35
-1% -$1.52K
GLRE icon
2466
Greenlight Captial
GLRE
$511M
$133K ﹤0.01%
10,699
IWX icon
2467
iShares Russell Top 200 Value ETF
IWX
$4.06B
$130K ﹤0.01%
2,434
-359
-13% -$19K
CSLT
2468
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$126K ﹤0.01%
46,500
VNTR
2469
DELISTED
Venator Materials PLC
VNTR
$124K ﹤0.01%
13,800
AKAO
2470
DELISTED
Achaogen Inc
AKAO
$122K ﹤0.01%
30,496
TWI icon
2471
Titan International
TWI
$478M
$122K ﹤0.01%
16,398
UL icon
2472
Unilever
UL
$136B
$121K ﹤0.01%
1,959
SCHB icon
2473
Schwab US Broad Market ETF
SCHB
$44.8B
$120K ﹤0.01%
10,230
AMR
2474
DELISTED
Alta Mesa Resources Inc
AMR
$117K ﹤0.01%
28,100
ANW
2475
DELISTED
Aegean Marine Petroleum Network
ANW
$117K ﹤0.01%
+82,005
New +$138K

Similar funds

UBS AM's Q3 2018 Portfolio in Review

As of Q3 2018, UBS AM held 2,869 positions worth $135B, up 3.1% from $130B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS AM's Q3 2018 filing shows 86 new, 1,174 increased, 804 reduced and 106 closed positions. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M. The largest sale was Scotiabank, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • UBS AM's largest Q3 2018 buy was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M.
  • UBS AM added most to Allergan plc in Q3 2018, an estimated $155M increase.
  • UBS AM's biggest Q3 2018 reduction was Scotiabank, cutting an estimated $255M.
  • UBS AM fully exited BCE in Q3 2018, selling an estimated $35M.
  • UBS AM's ten largest holdings make up 18% of its $135B portfolio in Q3 2018.
  • UBS AM opened 86 new positions and closed 106 in Q3 2018.
  • UBS AM's portfolio value rose 3.1% quarter-over-quarter to $135B.

Based on UBS AM's 13F filing for Q3 2018, filed 14 Nov 2018.